FindTrial
Sign In

A clinical trial to study the pain relieving effect of two different doses of buprenorphine patch in post-operative pain relief in patients undergoing laparoscopic surgeries under general anaesthesia

Comparative study between transdermal buprenorphine patch 5 mcg/hour and 10 mcg/hour in post-operative pain management administered pre-emptively in laparoscopic surgeries under general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052229
Enrollment
90
Registered
2023-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K35-K38- Diseases of appendix Health Condition 2: N00-N99- Diseases of the genitourinary system Health Condition 3: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 4: K40-K46- Hernia Health Condition 5: O- Medical and Surgical Health Condition 6: 1- Obstetrics Health Condition 7: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: PRE-OPERATIVE ADMINISTRATION OF TRASDERMAL BUPRENORPHINE PATCH: ADMINISTERED 12 HOURS BEFORE SURGERY IN PATIENTS UNDER LAPAROSCOPIC SURGERIES UNDER GA. IT IS ADMINSTERED ONCE. IT RELEAS

Sponsors

ESIC MEDICAL AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I, II Patients posted for laparoscopic surgeries under GA

Exclusion criteria

Exclusion criteria: • Patient refusal • Patients with skin allergy • Patients with severe hepatic and renal dysfunction • Pregnant and lactating women • Bleeding disorders • Respiratory diseases such as chronic obstructive pulmonary disease, bronchial asthma • Hypersensitivity to study drug • Epileptic patients • ASA III ,IV

Design outcomes

Primary

MeasureTime frame
Pain-free duration measured using VAS scaleTimepoint: From the time of extubation upto 48 hours—

Secondary

MeasureTime frame
The amount of analgesics required over 48 hrs. Variation in heart rate, NIBP, MAP intra- operatively. Level of sedation using Ramsay sedation scale Timepoint: serially upto 48 hours—

Countries

India

Contacts

Public ContactDR ZAINAB HAMEEDA BEGAM S

ESIC MEDICAL COLLEGE AND HOSPITAL , K.K. NAGAR .

zainabsulthan@gmail.com7550040977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026